
IGOMU ELAYONI
Veterinary Microbiologist, Poultry Vaccine expert
less
Related Authors
Jon R Sayers
The University of Sheffield
Uwamere O Edeghor
University of Calabar, Calabar, Nigeria.
Alaa Abed
Al-Qadisiya University
John Egbere
UNIVERSITY OF JOS, NIGERIA
Pradipta Saha
Burdwan University
RADHIA AITFELLA LAHLOU
University Of Boumerdes Algeria
James Ebdon
University of Brighton
Angela Alviz
Texas Tech University
OSUNTOKUN OLUDARE TEMITOPE (Orcid ID.0000-0002-3954-6778), Web of Science ResearcherID -L-4314-2016
Adekunle Ajasin University, Akungba-Akoko, Nigeria
Jana Javornik
University of East London
Uploads
Papers by IGOMU ELAYONI
underreported across the continent. In Nigeria, poverty, inter country livestock trades, nomadic system of cattle
production, indiscriminate use of antibiotics and prevalent immuno-compromising diseases such as human
immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and tuberculosis are factors that have
enabled ease of transmission and complications of S. Kentucky infections. In the present decade, S. Kentucky is
reported to be the most prevalent serovar associated with poultry in Nigeria, but very few reports underline the
risk associated with consumption of poultry and acquisition of MDR S. Kentucky strains. The Nigerian poultry is one
of the most commercialized subsectors of Nigerian agriculture, therefore, the presence of S. Kentucky especially
strains carrying broad spectrum antimicrobial resistance pose a great risk to public health. The lack of proper
monitoring, surveillance, isolation and control of the multidrug resistant S. Kentucky will remain a challenge to the
export potential of the Nigerian poultry subsector and livestock in general. As a nation, modalities and actions
against the smuggling of poultry products, indiscriminate use of antibiotics and nomadic system for the production
of dairy and beef that promotes spread of virulent strains of Salmonellae must change. The impact of non-typhoidal
salmonellosis in humans in Nigeria also remains under studied and under reported, especially those caused by S.
Kentucky ST198. Compounding these concerns is the lack of commercial veterinary or human vaccines against S.
Kentucky or where vaccines against the broad serogroup C non-typhoidal Salmonella (NTS) are available, they are
rarely supplied, with no evidence they could be cross-protective. This review emphasizes the emergence and
widespread occurrence of MDR S. Kentucky strains on the African continent, and discussed risk factors contributing
to its spread in Nigeria and the potential public health challenge especially to high-risk immunocompromised
individuals.
underreported across the continent. In Nigeria, poverty, inter country livestock trades, nomadic system of cattle
production, indiscriminate use of antibiotics and prevalent immuno-compromising diseases such as human
immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) and tuberculosis are factors that have
enabled ease of transmission and complications of S. Kentucky infections. In the present decade, S. Kentucky is
reported to be the most prevalent serovar associated with poultry in Nigeria, but very few reports underline the
risk associated with consumption of poultry and acquisition of MDR S. Kentucky strains. The Nigerian poultry is one
of the most commercialized subsectors of Nigerian agriculture, therefore, the presence of S. Kentucky especially
strains carrying broad spectrum antimicrobial resistance pose a great risk to public health. The lack of proper
monitoring, surveillance, isolation and control of the multidrug resistant S. Kentucky will remain a challenge to the
export potential of the Nigerian poultry subsector and livestock in general. As a nation, modalities and actions
against the smuggling of poultry products, indiscriminate use of antibiotics and nomadic system for the production
of dairy and beef that promotes spread of virulent strains of Salmonellae must change. The impact of non-typhoidal
salmonellosis in humans in Nigeria also remains under studied and under reported, especially those caused by S.
Kentucky ST198. Compounding these concerns is the lack of commercial veterinary or human vaccines against S.
Kentucky or where vaccines against the broad serogroup C non-typhoidal Salmonella (NTS) are available, they are
rarely supplied, with no evidence they could be cross-protective. This review emphasizes the emergence and
widespread occurrence of MDR S. Kentucky strains on the African continent, and discussed risk factors contributing
to its spread in Nigeria and the potential public health challenge especially to high-risk immunocompromised
individuals.